TOREMIFENE CITRATE Drug Patent Profile
✉ Email this page to a colleague
When do Toremifene Citrate patents expire, and when can generic versions of Toremifene Citrate launch?
Toremifene Citrate is a drug marketed by MSN and Rising and is included in two NDAs.
The generic ingredient in TOREMIFENE CITRATE is toremifene citrate. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the toremifene citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Toremifene Citrate
A generic version of TOREMIFENE CITRATE was approved as toremifene citrate by RISING on December 4th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOREMIFENE CITRATE?
- What are the global sales for TOREMIFENE CITRATE?
- What is Average Wholesale Price for TOREMIFENE CITRATE?
Summary for TOREMIFENE CITRATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Clinical Trials: | 6 |
| Patent Applications: | 8,470 |
| DailyMed Link: | TOREMIFENE CITRATE at DailyMed |
Recent Clinical Trials for TOREMIFENE CITRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 4 |
| Fred Hutchinson Cancer Research Center | Phase 4 |
| Federal University of São Paulo | Phase 4 |
Pharmacology for TOREMIFENE CITRATE
| Drug Class | Estrogen Agonist/Antagonist |
| Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for TOREMIFENE CITRATE
Anatomical Therapeutic Chemical (ATC) Classes for TOREMIFENE CITRATE
US Patents and Regulatory Information for TOREMIFENE CITRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msn | TOREMIFENE CITRATE | toremifene citrate | TABLET;ORAL | 212818-001 | Aug 18, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | TOREMIFENE CITRATE | toremifene citrate | TABLET;ORAL | 208813-001 | Dec 4, 2018 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
